Naczyniak
Diagnostyka i diagnoza

Naczyniak niemowlęcy to najczęstszy łagodny nowotwór okresu niemowlęcego, wynikający z proliferacji komórek śródbłonka naczyniowego, charakteryzujący się szybkim wzrostem w pierwszych 6-9 miesiącach życia (faza proliferacji) i powolną inwolucją. Diagnostyka opiera się głównie na badaniu klinicznym, uwzględniającym wiek wystąpienia (90% do 6 miesiąca życia), charakterystyczny kolor (różowy do czerwonego dla naczyniaków powierzchownych, niebieskawy dla głębokich) oraz lokalizację (60% głowa i szyja). Wskazane jest wykonanie badań obrazowych, takich jak USG z Dopplerem (czułość do 97% dla naczyniaków wątroby), MRI (czułość 92-100%, swoistość 85,7-99,4%) oraz CT z kontrastem, zwłaszcza w przypadku głębokich lub segmentalnych zmian, podejrzenia powikłań lub różnicowania z innymi guzami. Biopsja i badanie immunohistochemiczne z markerem GLUT-1 są zarezerwowane dla wątpliwych przypadków diagnostycznych, gdyż GLUT-1 jest specyficzny dla naczyniaków niemowlęcych.

Diagnostyka naczyniaka

Naczyniak (hemangioma) to najczęstszy łagodny nowotwór okresu niemowlęcego, spowodowany proliferacją komórek śródbłonka naczyniowego. Większość naczyniaków niemowlęcych jest diagnozowana na podstawie badania klinicznego, a dodatkowe badania diagnostyczne zazwyczaj nie są konieczne, chyba że istnieją wątpliwości co do rozpoznania lub potrzeba oceny zasięgu zmiany12.

Diagnostyka kliniczna

W większości przypadków rozpoznanie naczyniaka opiera się na badaniu fizykalnym i zebraniu szczegółowego wywiadu. Lekarze są w stanie zdiagnozować naczyniak na podstawie jego charakterystycznego wyglądu i przebiegu klinicznego34. Typowy naczyniak niemowlęcy charakteryzuje się szybkim wzrostem w pierwszych 6-9 miesiącach życia (faza proliferacji), a następnie powolnym zanikaniem (faza inwolucji)5.

Kluczowe elementy diagnostyki klinicznej obejmują67:

  • Wiek wystąpienia – większość naczyniaków niemowlęcych pojawia się w pierwszych tygodniach życia (30% obecnych przy urodzeniu, 50% do 1-2 miesiąca, 90% do 6 miesiąca życia)8
  • Charakterystyczny kolor – od różowego do intensywnie czerwonego (naczyniaki powierzchowne) lub niebieskawego (naczyniaki głębokie)
  • Dynamiczny wzrost w pierwszych miesiącach życia
  • Lokalizacja – najczęściej głowa i szyja (60%), tułów (25%) i kończyny (15%)9

1011

Wczesne wykrycie naczyniaków zagrożonych powikłaniami jest kluczowe i wymaga zwiększonej świadomości wśród pediatrów, lekarzy podstawowej opieki zdrowotnej i innych specjalistów, aby zidentyfikować potencjalnie problematyczne naczyniaki w ciągu pierwszych 2-3 tygodni życia12.

Badania obrazowe

Badania obrazowe są wskazane w celu potwierdzenia rozpoznania i oceny zasięgu głębokich naczyniaków bez zmian powierzchownych, a także w celu wykluczenia nieprawidłowości towarzyszących i różnicowania proliferujących naczyniaków niemowlęcych od innych guzów13. Do najczęściej stosowanych badań obrazowych należą:

Ultrasonografia

Badanie ultrasonograficzne (USG) z opcją Dopplera to metoda pierwszego wyboru, która jest szczególnie przydatna do oceny głębokości naczyniaka i przepływu krwi przez zmianę1415. USG pozwala również na monitorowanie wielkości i przepływu krwi w naczyniaku w czasie jego leczenia16. Ultrasonografia charakteryzuje się wysoką czułością, dochodzącą do 97% w przypadku naczyniaków wątroby17.

W badaniu USG naczyniak jawi się jako dobrze odgraniczona, czasem zrazikowa, jednorodnie hiperechogeniczna zmiana z wzmocnieniem akustycznym za zmianą, często zlokalizowana w pobliżu żyły wrotnej lub wątrobowej18. Badanie dopplerowskie może wykazać wysokoprzepływowe tętnicze i niskooporowe żylne spektrum przepływu19.

Rezonans magnetyczny

Rezonans magnetyczny (MRI) to badanie z wyboru do oceny lokalizacji i zasięgu naczyniaków, szczególnie w przypadku naczyniaków segmentalnych związanych z powikłaniami i anomaliami rozwojowymi20. Jest to również preferowana metoda do oceny naczyniaka kręgosłupa21.

MRI z kontrastem i bez kontrastu pozwala na dokładne zobrazowanie zarówno naczyniaków skórnych, jak i pozaskórnych22. W przypadku naczyniaków wątroby, MRI wykazuje czułość w zakresie 92-100% i swoistość rzędu 85,7-99,4%23.

W obrazach MRI naczyniak przedstawia się jako dobrze odgraniczona, jednorodnie hiperintensywna zmiana w obrazach T2-zależnych, jednorodnie hipointensywna w obrazach T1-zależnych, z obwodowym guzkowym wzmocnieniem, które postępuje do całkowitego i przedłużonego wypełnienia w dynamicznych obrazach wzmocnionych gadolinem24.

Tomografia komputerowa

Tomografia komputerowa (CT) z kontrastem może być również stosowana do diagnostyki naczyniaków25. W badaniu CT naczyniaki wykazują obwodowe guzkowe wzmocnienie, które postępuje od obwodu zmiany do jej centrum, aż cała zmiana wykazuje jednorodne długotrwałe wzmocnienie, odpowiadające wzmocnieniu żył26.

Badania histopatologiczne

Biopsja i badanie histopatologiczne są wymagane tylko wtedy, gdy zmianę naczyniakową trzeba odróżnić od guzów naczyniowych o granicznej złośliwości lub guzów złośliwych27. W przypadku wątpliwości diagnostycznych, biopsja skóry może pomóc w odróżnieniu nietypowych naczyniaków od innych zmian naczyniowych28.

Immunohistochemicznie, naczyniaki niemowlęce wykazują dodatnie barwienie na GLUT-1 (transporter glukozy 1), co pomaga odróżnić je od innych guzów naczyniowych lub malformacji naczyniowych2930. Dodatnie barwienie na GLUT-1 jest charakterystyczne dla naczyniaków niemowlęcych, podczas gdy inne zmiany naczyniowe są zazwyczaj GLUT-1 negatywne31.

Histopatologicznie, naczyniaki w fazie proliferacyjnej składają się z zrazikowych skupisk naczyń włosowatych wyścielonych przez obrzmiałe, mitotycznie aktywne komórki śródbłonka otoczone przez perycyty32.

Szczególne sytuacje diagnostyczne

Naczyniaki wymagające specjalistycznej oceny

Niektóre naczyniaki mogą być problematyczne, wymagając szybkiej identyfikacji i wczesnego leczenia i/lub skierowania do specjalisty33. Pacjent z naczyniakiem niemowlęcym zagrożonym powikłaniami powinien zostać skierowany do wielodyscyplinarnego zespołu w celu oceny, specyficznych badań diagnostycznych (np. rezonansu magnetycznego, badań przesiewowych w kierunku niedoczynności tarczycy lub nieprawidłowości krzepnięcia) i odpowiedniego leczenia34.

Wskazania do skierowania do specjalisty mogą obejmować35:

  • Naczyniaki w okolicach oka, nosa, ust, uszu – mogące prowadzić do zaburzeń funkcji
  • Naczyniaki segmentalne lub liczne
  • Naczyniaki z objawami owrzodzenia lub krwawienia
  • Naczyniaki zagrażające funkcjom życiowym (np. drogi oddechowe)
  • Naczyniaki z potencjałem do znacznego zniekształcenia

36

Zespoły związane z naczyniakami

W przypadku dużych, segmentalnych naczyniaków niemowlęcych, lekarze powinni rozważyć skojarzenia zespołowe, takie jak zespół PHACE, wymagający obrazowania serca i oceny okulistycznej37. W przypadku obecności sześciu lub więcej naczyniaków niemowlęcych, zalecane jest badanie wątroby i śledziony w celu wykrycia ewentualnych naczyniaków wewnętrznych38.

Testy diagnostyczne mogą obejmować39:

  • Badania obrazowe głowy, szyi lub brzucha w poszukiwaniu anomalii strukturalnych
  • Badania funkcji tarczycy i wątroby w przypadku podejrzenia zajęcia narządów wewnętrznych
  • Echokardiografię w przypadku podejrzenia zespołu PHACE
  • Laryngoskopię w przypadku stridoru z towarzyszącymi zmianami w okolicy brody

Naczyniaki narządowe

Naczyniaki mogą występować również w narządach wewnętrznych, najczęściej w wątrobie. Naczyniak wątroby (naczyniak krwionośny wątroby) to nienowotworowy guz wątroby, który jest najczęstszym łagodnym guzem wątroby40.

Diagnostyka naczyniaków wątroby opiera się głównie na badaniach obrazowych41:

  • Ultrasonografia z kontrastem
  • Tomografia komputerowa
  • Rezonans magnetyczny
  • Scyntygrafia z wykorzystaniem znakowanych technetem-99m krwinek czerwonych

42

Według American College of Gastroenterology (ACG) i European Association for the Study of the Liver (EASL), znalezienie małej zmiany (≤2 cm dla ACG; ≤3 cm dla EASL) o klasycznych cechach obrazowych u pacjenta bez przewlekłej choroby wątroby lub bez rozpoznania onkologicznego można uznać za diagnostyczne dla naczyniaka wątroby43.

Diagnostyka różnicowa

Rozpoznanie różnicowe naczyniaków obejmuje4445:

  • Malformacje naczyniowe – obecne od urodzenia, nie zanikają samoistnie
  • Guzy naczyniowe złośliwe, takie jak angiosarcoma
  • Inne guzy łagodne skóry i tkanek miękkich
  • W przypadku naczyniaków wątroby – ogniskowy rozrost guzkowy, gruczolak wątrobowokomórkowy, przerzuty
  • W przypadku naczyniaków naczyniówki oka – czerniak naczyniówki bezbarwnikowy, przerzut do naczyniówki, zapalenie tylnej części twardówki, gruczolak naczyniówki

46

Poprawne różnicowanie naczyniaków od innych zmian jest kluczowe dla właściwego postępowania. Błędna diagnoza pozostaje główną przeszkodą w optymalnej ocenie i leczeniu47.

Znaczenie wczesnej diagnostyki

Wczesna i dokładna diagnoza oraz leczenie jest kluczem do osiągnięcia optymalnych wyników48. Wczesna interwencja i/lub skierowanie (najlepiej do 1 miesiąca życia) jest zalecane dla niemowląt, które mają potencjalnie problematyczne naczyniaki niemowlęce49.

Najszybszy okres wzrostu naczyniaka niemowlęcego przypada na pierwsze osiem tygodni życia. Jeśli można zmienić tempo wzrostu w tym okresie, prawdopodobnie zapewnia to dziecku najlepszy długoterminowy wynik50.

Każde dziecko, u którego istnieje obawa o możliwość wystąpienia jakichkolwiek powikłań związanych z naczyniakiem, powinno trafić do specjalisty zajmującego się leczeniem naczyniaków w ciągu pierwszego miesiąca życia51.

Prognoza i naturalna historia

Rokowanie jest bardzo dobre dla niepowikłanych naczyniaków niemowlęcych, a w większości przypadków dochodzi do całkowitej inwolucji52:

  • 50% naczyniaków ustępuje w ciągu 5 lat
  • 70% ustępuje do 7 roku życia
  • 90% ustępuje do 9 roku życia

53

Około 8% naczyniaków niemowlęcych pozostawia zniekształcenia kosmetyczne i wymaga pewnej interwencji54. Większość naczyniaków niemowlęcych jest nieszkodliwa dla dziecka – rosną w pierwszym roku życia, a następnie powoli, stopniowo zanikają55.

Typowy przebieg naczyniaków charakteryzuje się początkowym powiększeniem, a następnie samoistną regresją56. Naczyniak może pozostawić po sobie zmiany skórne i blizny, które mogą wpływać na samoocenę dziecka57.

Podsumowanie diagnostyki

Diagnostyka naczyniaków opiera się przede wszystkim na szczegółowym wywiadzie i badaniu fizykalnym. Dwa kluczowe pytania to: czy zmiana była obecna przy urodzeniu oraz czy po urodzeniu nastąpił proporcjonalny czy nieproporcjonalny wzrost zmiany58.

W przypadkach, gdy samo badanie kliniczne nie jest jednoznaczne, można wykorzystać inne metody diagnostyczne, takie jak ultrasonografia i rezonans magnetyczny59. Badania obrazowe są szczególnie przydatne do potwierdzenia diagnozy klinicznej, oszacowania zasięgu zmiany i określenia możliwości resekcji chirurgicznej60.

Rozpoznanie naczyniaka niemowlęcego jest zazwyczaj proste w przypadku typowych zmian, jednakże w przypadku zmian nietypowych konieczne może być przeprowadzenie dodatkowych badań diagnostycznych, w tym biopsji i badania immunohistochemicznego z użyciem markera GLUT-1, który jest charakterystyczny dla naczyniaków niemowlęcych61.

Wczesne rozpoznanie naczyniaków zagrożonych powikłaniami jest kluczowe i wymaga zwiększonej świadomości wśród lekarzy, aby identyfikować potencjalnie problematyczne naczyniaki niemowlęce w ciągu pierwszych 2-3 tygodni życia, aby można je było leczyć we wczesnej fazie proliferacji62.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Hemangioma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538232/
    Hemangiomas, colloquially termed „strawberry marks”, are the most common benign tumor of infancy and are caused by endothelial cell proliferation. […] Most Infantile hemangiomas are diagnosed clinically. A skin biopsy can be performed if there is any doubt. Infantile hemangiomas stain positive for GLUT 1. Imaging studies like ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are indicated to confirm the diagnosis and the extent of deep IH without superficial changes. This is done to rule out associated anomalies and to differentiate proliferating IH from other tumors. […] The prognosis is very good for uncomplicated IH and there is complete involution in the majority of cases. 50% of hemangiomas will resolve in 5 years, 70% by 7 years and 90% by 9 years. Approximately 8% of IH leave cosmetic disfigurement and require some intervention.
  • #2 Hemangioma: Types, Diagnosis and Treatment Options
    https://www.nationwidechildrens.org/conditions/hemangioma
    Your childs doctor or health care provider can usually look at their skin to see a hemangioma. If they cant tell, your child may need an imaging test, like an ultrasound. […] If your childs hemangioma needs to be treated, their doctor or health care provider will talk to you about options. Treatment depends on the size, location, and if its causing any problems for your child.
  • #3 Hemangioma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/hemangioma/diagnosis-treatment/drc-20352339
    In most cases, a health care provider can diagnose a hemangioma by looking at it. Tests typically aren’t needed. […] Most infantile hemangiomas will be harmless to the child. They’ll grow within the first year of life and then slowly go away little by little. However, there are a subset of infantile hemangiomas that can be quite harmful and even have complications that it really should be identified quickly and treated by a specialist. […] The question often comes up when is the best time to have someone that has an infantile hemangioma be seen by a specialist and we did recently complete a study along with some colleagues at the University of California in San Francisco that the most rapid time of growth of an infantile hemangioma is actually the first eight weeks of life, and so if we can alter that rate of growth at some point within that eight weeks that probably leaves a child with the best outcome in the long run.
  • #4 Hemangioma Types, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/23365-hemangioma
    Hemangiomas usually arent dangerous. But if they grow in a critical area, they can press on and eventually damage surrounding tissues, which can make them dangerous. How dangerous depends mainly on where exactly they are. […] Hemangiomas, especially ones on your skin, often stand out. Healthcare providers may notice them during routine physical exams. […] Healthcare providers can assess hemangiomas using simple devices like ultrasound. This imaging method is especially useful with hemangiomas because of the blood flowing through them. Other tests, like a biopsy to test the tissue and determine what it is, are possible but not always necessary. […] In some cases, your healthcare provider might recommend additional imaging like MRI. Scans like this can help your provider check for potential risks that arent visible from the outside. And other tests, like blood tests or even genetic tests, may help your provider diagnose a hemangioma or rule out other conditions. Your healthcare provider can tell you more about the tests they recommend for your situation.
  • #5 Diagnosis of Hemangiomas | SpringerLink
    https://link.springer.com/chapter/10.1007/978-88-470-0569-3_5
    Diagnosis of hemangiomas is based first on the medical history. The presence of a lesion at birth supports a diagnosis of a vascular malformation or congenital hemangioma. Infantile hemangiomas are characterized by an initial rapid proliferation phase in the first 69 months of life, followed by a slow involution phase and, in many cases, complete regression. Physical examination should allow a hemangioma to be classified as superficial, deep, or mixed type. On imaging, Doppler ultrasound (US) can assess the flow dynamics of a hemangioma, but the most important tool is contrast-enhanced magnetic resonance imaging (MRI), which demonstrates the extent of the lesion and can help to differentiate between a hemangioma and another disorder. The type of lesion can usually be determined based on the physical examination and Doppler US. MRI is mostly useful for confirming the clinical diagnosis, estimating the extent of the lesion, and determining the feasibility of surgical resection. If the diagnosis is in question after a thorough history, physical examination and radiological findings, a skin biopsy can be helpful in distinguishing unusual or atypical hemangiomas from other vascular lesions.
  • #6 Infantile hemangioma: timely diagnosis and treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8566800/
    Infantile hemangiomas (IHs) are usually diagnosed clinically. Biopsy and pathological diagnosis are required only when the IH lesion must be differentiated from borderline or malignant vascular tumors. […] A patient with IH who is at risk of complications should be referred to a multidisciplinary team for evaluation, specific diagnostic measures (e.g., magnetic resonance imaging, screening for hypothyroidism, or coagulation abnormalities), and specific treatment. […] The early detection of at-risk IHs is a major point requiring increased awareness by pediatricians, general practitioners, and health specialists to identify potentially problematic IHs within the first 2-3 weeks of life so that they can be treated during the early stage of proliferation. […] While the majority of infantile hemangiomas (IHs) do not require therapy and regress spontaneously, about 10%-15% develop complications such as ulceration, obstruction, or disfigurement. Early intervention is recommended for infants with potentially problematic IHs. Oral propranolol 2-3 mg/kg/day is currently the treatment of choice.
  • #7 Hemangioma – Symptoms, diagnosis and treatment | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/1041
    Benign vascular lesions that typically appear during the first weeks of life as blue or pink macules or patches. […] Some lesions can be problematic, requiring identification and early treatment and/or referral. […] Key diagnostic factors include variable onset, pink, red, or blue color, rapid growth, variable compressibility, and flat or nodular character. […] 1st tests to order include Doppler ultrasound of hemangioma. […] Tests to consider include MRI (without and with IV contrast) of hemangioma and biopsy of lesion.
  • #8 Capillary Hemangioma – EyeWiki
    https://eyewiki.org/Capillary_Hemangioma
    Capillary hemangioma (infantile hemangioma, juvenile hemangioma, or strawberry nevus of infancy) is one of the most common benign orbital tumors of childhood affecting up to 5% of infants under the age of 1 year. […] The diagnosis is made clinically, however in extensive cases imaging helps delineate the extent of orbital involvement. […] Presentation of capillary hemangiomas usually occurs after birth, but within the first 6 months of life (30% present at birth, 50% by 1-2 months, and 90% by 6 months). […] Although the diagnosis is clinical in cutaneous lesions, ultrasound should be used to image the extent of periorbital involvement. If deeper orbital extension is suspected, then CT or MRI may be used. […] The first-line of treatment for periorbital hemangiomas that may affect the visual development consists of -blockers.
  • #9 Diagnosis and Treatment of Cutaneous Vascular Lesions | AAFP
    https://www.aafp.org/pubs/afp/issues/1998/0215/p765.html
    Hemangioma is the most common benign neoplasm of infancy, occurring in 1 to 3 percent of newborns. […] The incidence of hemangiomas is elevated in female infants (two to five times higher than in male infants) and premature infants (especially those weighing less than 1,500 g [3 lb, 4.5 oz]). […] Ninety percent of hemangiomas are detected in the first month of life and may occur on the head and neck (60 percent), trunk (25 percent) and extremities (15 percent). […] Nodules develop by two to four weeks of age, marking the six- to 12-month proliferative phase characteristic of hemangiomas. […] Full regression occurs in 50 percent of patients by age five, in 70 percent by age seven and in 90 percent by age nine. […] Most hemangiomas require no specific therapy other than patient education and reassurance.
  • #10 Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review
    https://www.mdpi.com/2227-9067/11/11/1397
    Infantile haemangiomas (IHs) affect 3–10% of infants, 10% of whom need topical or systemic beta-blocker therapy. […] This review aims to summarise the epidemiology, clinical presentation, diagnosis, and treatment of IHs and to highlight the importance of proper referral to specialised hub centres. Patients with vascular anomalies, particularly those suspected of having IH, should be referred to a specialised centre for accurate diagnosis, management by a multidisciplinary team, and timely treatment. […] IHs are generally diagnosed clinically. Imaging studies (i.e., ultrasound (US) and MRI) and other investigations (i.e., colorimetry) are required for special situations. […] The purpose of US is to evaluate the depth and size of the lesions, check for intrahepatic lesions, and rule out renal and urogenital anomalies and spinal dysraphism.
  • #11 Haemangioma – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-gb/1041
    Benign vascular lesions that typically appear during the first weeks of life as blue or pink macules or patches. […] Some lesions can be problematic, requiring identification and early treatment and/or referral. […] Key diagnostic factors: presence of risk factors, variable onset, pink, red, or blue colour, rapid growth, variable compressibility, flat or nodular character. […] 1st investigations to order: Doppler ultrasound of haemangioma. […] Investigations to consider: MRI (without and with IV contrast) of haemangioma, biopsy of lesion.
  • #12 Infantile hemangioma: timely diagnosis and treatment
    http://e-cep.org/journal/view.php?doi=10.3345/cep.2021.00752
    Infantile hemangiomas (IHs) are usually diagnosed clinically. […] Biopsy and pathological diagnosis are required only when the IH lesion must be differentiated from borderline or malignant vascular tumors. […] Imaging studies and other investigations are required in special situations. […] A patient with IH who is at risk of complications should be referred to a multidisciplinary team for evaluation, specific diagnostic measures (e.g., magnetic resonance imaging, screening for hypothyroidism, or coagulation abnormalities), and specific treatment. […] The early detection of at-risk IHs is a major point requiring increased awareness by pediatricians, general practitioners, and health specialists to identify potentially problematic IHs within the first 2-3 weeks of life so that they can be treated during the early stage of proliferation.
  • #13 Hemangioma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538232/
    Hemangiomas, colloquially termed „strawberry marks”, are the most common benign tumor of infancy and are caused by endothelial cell proliferation. […] Most Infantile hemangiomas are diagnosed clinically. A skin biopsy can be performed if there is any doubt. Infantile hemangiomas stain positive for GLUT 1. Imaging studies like ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are indicated to confirm the diagnosis and the extent of deep IH without superficial changes. This is done to rule out associated anomalies and to differentiate proliferating IH from other tumors. […] The prognosis is very good for uncomplicated IH and there is complete involution in the majority of cases. 50% of hemangiomas will resolve in 5 years, 70% by 7 years and 90% by 9 years. Approximately 8% of IH leave cosmetic disfigurement and require some intervention.
  • #14 Hemangioma Types, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/23365-hemangioma
    Hemangiomas usually arent dangerous. But if they grow in a critical area, they can press on and eventually damage surrounding tissues, which can make them dangerous. How dangerous depends mainly on where exactly they are. […] Hemangiomas, especially ones on your skin, often stand out. Healthcare providers may notice them during routine physical exams. […] Healthcare providers can assess hemangiomas using simple devices like ultrasound. This imaging method is especially useful with hemangiomas because of the blood flowing through them. Other tests, like a biopsy to test the tissue and determine what it is, are possible but not always necessary. […] In some cases, your healthcare provider might recommend additional imaging like MRI. Scans like this can help your provider check for potential risks that arent visible from the outside. And other tests, like blood tests or even genetic tests, may help your provider diagnose a hemangioma or rule out other conditions. Your healthcare provider can tell you more about the tests they recommend for your situation.
  • #15 Hemangioma | Boston Children’s Hospital
    https://www.childrenshospital.org/conditions/hemangioma
    Your visit will start with a complete medical history and a thorough physical exam. In most cases, the physician will be able to diagnose your child’s hemangioma simply by looking at it and reviewing the clinical history with the parent or caregiver. […] If more information is needed to confirm your child’s diagnosis, the physician may request an ultrasound. An ultrasound is an imaging test that uses sound wave technology to examine the size of the hemangioma and allows your doctor to see how much blood is flowing through it. […] In rare cases, the physician may need more information to confirm a diagnosis of more complicated hemangiomas. In this case, the physician may order a: […] MRI (magnetic resonance imaging): High-resolution scan that shows how large your child’s hemangioma is, as well as its relationship to nearby muscles, nerves, bones and other blood vessels. […] Biopsy: Surgical procedure that removes a small tissue sample for further testing of its cells under a microscope.
  • #16 Hepatic Hemangioma | Texas Children’s
    https://www.texaschildrens.org/content/conditions/hepatic-hemangioma
    Hemangiomas are benign (not cancer) growths of extra blood vessels. Similar to hemangiomas on the skin, children may develop hemangiomas in the liver. […] Clinical exam. Sometimes a physician may feel an enlarged liver during a normal evaluation. Usually the small liver hemangiomas are not detected by normal physical examination. […] Imaging is important for liver hemangiomas (ultrasound of the liver), both at diagnosis and as monitoring. It monitors the size and blood flow in the hemangioma. Does not use radiation and does not require sedation of the baby. […] Pathology. Hemangiomas are most often diagnosed by physical examination and so rarely require a biopsy (when a small piece of the liver is taken for examination under the microscope).
  • #17 Hepatic Hemangiomas Workup: Approach Considerations, Laboratory Studies, Imaging Studies
    https://emedicine.medscape.com/article/177106-workup
    Radiologic imaging is the key to making a diagnosis of hepatic hemangioma. The key modalities include ultrasonography, dynamic contrast-enhanced computed tomography (CT) scanning, and magnetic resonance imaging (MRI). Less commonly used imaging modalities include nuclear medicine studies using technetium-99m (99mTc)labeled red blood cells (RBCs), hepatic arteriography, and digital subtraction angiography (DSA). […] Ultrasound has a sensitivity as high as 97% and a specificity as high as 60% in the diagnosis of hepatic hemangioma. […] The American College of Gastroenterology (ACG) and the European Association for the Study of the Liver (EASL) both state that the finding of a small lesion ( 2 cm for ACG; 3 cm for EASL) with classic imaging characteristics in a patient without chronic liver disease or without an oncologic diagnosis can be considered to be diagnostic for hepatic hemangioma.
  • #18 What is changing in indications and treatment of hepatic hemangiomas. A review | Annals of Hepatology
    https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-what-is-changing-in-indications-S1665268119308397
    Different imaging modalities have been used in diagnosis of liver hemangioma including ultrasonography, computed tomography (CT), magnetic resonance (MR) imaging, and less frequently scintigraphy and positron-emission tomography combined with CT (PET/CT) and angiography. Imaging-guided biopsy of hemangioma is usually not resorted to except in extremely atypical cases. Specificity and sensitivity of all these procedures are reported in table 1. […] On ultrasonography, hemangioma appears well defined, occasionally lobulated, homogeneously hyperechoic with posterior acoustic enhancement, and frequently located close to a portal or a hepatic vein. […] On CT, hemangiomas show peripheral nodular enhancement, which progresses from the periphery of the lesion to its center until the whole lesion shows homogeneous prolonged enhancement, matching the enhancement of veins.
  • #19 Infantile hemangioma | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/infantile-haemangioma?lang=us
    Infantile hemangiomas are benign vascular neoplasms that are the most common head and neck tumors of infancy. They can occur virtually anywhere, but the majority are found in the head and neck regions. […] These tumors proliferate both through the growth of existing vessels as well as de novo blood vessel formation. Hemangioma progenitor cells, endothelial cells, and pericytes are the histologically identified cell types that comprise these lesions. Unlike other vascular tumors, they are GLUT-1 positive. […] Infantile hemangiomas are predominantly superficial soft-tissue lesions and thus can be easily assessed by ultrasound. They present as an echogenic well-defined mass that may exhibit prominent internal vascularity on color Doppler. High flow arterial and low resistance venous waveforms are demonstrated. […] These lesions are often initially observed. If treatment is to be enacted, options include anti-angiogenesis medications such as propranolol, embolization, sclerotherapy, radiotherapy, cryotherapy, laser therapy, and surgical excision.
  • #20 Tests & Diagnosis | Infantile Hemangioma
    https://infantilehemangioma.com/tests-diagnosis/
    Diagnosis A correct diagnosis is important so the doctor can properly treat your childs hemangioma. A doctor can diagnose a hemangioma by giving your child a physical exam and taking their medical history. If needed, a biopsy can be performed. The presence of GLUT-1 marker on a histochemical evaluation will differentiate infantile hemangioma from other forms of vascular anomalies. […] Tests Magnetic resonance imaging (MRI) is a test that uses a magnetic field and pulses of radio wave energy to make pictures of organs and structures inside the body. MRI is the test of choice to locate and examine segmental hemangiomas associated with complications and developmental anomalies. […] A skin biopsy is a procedure in which a sample of skin tissue is removed from the lesion and examined under a microscope. It is helpful for telling unusual hemangiomas apart from other types of damage in the blood vessels.
  • #21 Adult Spinal Hemangioma Symptoms, Diagnosis & Treatment | UPMC
    https://www.upmc.com/services/neurosurgery/spine/conditions/tumors-lesions/hemangioma
    Spinal hemangiomas are benign tumors most common in the mid back (thoracic) and lower back (lumbar). […] Our doctors use imaging tests, such as X-rays, CT scans, and MRIs, to diagnose hemangiomas. […] If your doctor thinks you may have a hemangioma, they’ll run imaging tests: […] An MRI can also show the extent of nerve damage in the spine and help plan surgical treatment.
  • #22 Infantile Hemangioma Workup: Laboratory Studies, Imaging Studies, Procedures
    https://emedicine.medscape.com/article/1083849-workup
    No laboratory studies have been universally accepted for the diagnosis and treatment of infantile hemangiomas; however, reports in the literature have investigated the use of serum vascular endothelial growth factor (VEGF) as well as urinary beta-fibroblast growth factor, VEGF, and matrix metalloproteinases (MMPs) as markers of hemangioma proliferation and differentiation. […] Use of glucose transporter 1 (GLUT-1) stain is helpful for evaluating tissue removed during biopsy or excision. […] MRI with and without intravenous gadolinium is the imaging modality of choice to delineate the location and extent of both cutaneous and extracutaneous hemangiomas. […] If the diagnosis is in question after a thorough history and physical examination, a skin biopsy can be helpful in distinguishing unusual or atypical hemangiomas from other vascular lesions. […] Specimens may be evaluated for tissue-specific immunohistochemical markers such as GLUT-1, merosin, Fc-gamma-RII, and Lewis Y antigens. These markers may aid in differentiating infantile hemangiomas (positive staining for all) from other vascular neoplasms or malformations.
  • #23 Hepatic Hemangiomas Workup: Approach Considerations, Laboratory Studies, Imaging Studies
    https://emedicine.medscape.com/article/177106-workup
    The sensitivity for MRI detection of hepatic hemangioma is in the range of 92-100%, with a specificity in the range of 85.7-99.4%. […] In the authors’ opinions, MRI with arterial phase and delayed contrast medium is the test of choice for investigating a liver mass of unclear origin. This is particularly the case when hepatic hemangioma is suspected.
  • #24 What is changing in indications and treatment of hepatic hemangiomas. A review | Annals of Hepatology
    https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-what-is-changing-in-indications-S1665268119308397
    On MR imaging, hemangioma appears well defined, homogeneously hyperintense on T2-weighted images, homogeneously hypointense on T1-weighted images, with peripheral nodular enhancement that progresses to complete and prolonged fill-in on the dynamic gadolinium-enhanced images. […] Persistent non-enhancing component within the hemangioma may be due to thrombosis, sclerosis, scarring, hyalinization, or cystic clefts within the hemangioma. Diagnosis of hemangioma remains to be easy if the hemangioma is large enough to show the characteristic features at the periphery of the lesion. […] The right indications for surgery remain strictly related to the tumor complications. In fact rupture, intratumoral bleeding, Kasabach-Merritt syndrome and organ or vessels compression (gastric outlet obstruction, Budd-Chiari syndrome, etc.) represents the valid indication for surgery and at the same time they are all complications of the tumor itself. The size of the tumor do not represent a valid indication for treatment.
  • #25 Liver hemangioma – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/liver-hemangioma/diagnosis-treatment/drc-20354239
    Tests used to diagnose liver hemangiomas include: […] Ultrasound, an imaging method that uses high-frequency sound waves to produce images of the liver […] Computerized tomography (CT) scanning, which combines a series of X-ray images taken from different angles around your body and uses computer processing to create cross-sectional images (slices) of the liver […] Magnetic resonance imaging (MRI), a technique that uses a magnetic field and radio waves to create detailed images of the liver […] Scintigraphy, a type of nuclear imaging that uses a radioactive tracer material to produce images of the liver. […] Other tests may be used depending on your situation.
  • #26 What is changing in indications and treatment of hepatic hemangiomas. A review | Annals of Hepatology
    https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-what-is-changing-in-indications-S1665268119308397
    Different imaging modalities have been used in diagnosis of liver hemangioma including ultrasonography, computed tomography (CT), magnetic resonance (MR) imaging, and less frequently scintigraphy and positron-emission tomography combined with CT (PET/CT) and angiography. Imaging-guided biopsy of hemangioma is usually not resorted to except in extremely atypical cases. Specificity and sensitivity of all these procedures are reported in table 1. […] On ultrasonography, hemangioma appears well defined, occasionally lobulated, homogeneously hyperechoic with posterior acoustic enhancement, and frequently located close to a portal or a hepatic vein. […] On CT, hemangiomas show peripheral nodular enhancement, which progresses from the periphery of the lesion to its center until the whole lesion shows homogeneous prolonged enhancement, matching the enhancement of veins.
  • #27 Infantile hemangioma: timely diagnosis and treatment
    http://e-cep.org/journal/view.php?doi=10.3345/cep.2021.00752
    Infantile hemangiomas (IHs) are usually diagnosed clinically. […] Biopsy and pathological diagnosis are required only when the IH lesion must be differentiated from borderline or malignant vascular tumors. […] Imaging studies and other investigations are required in special situations. […] A patient with IH who is at risk of complications should be referred to a multidisciplinary team for evaluation, specific diagnostic measures (e.g., magnetic resonance imaging, screening for hypothyroidism, or coagulation abnormalities), and specific treatment. […] The early detection of at-risk IHs is a major point requiring increased awareness by pediatricians, general practitioners, and health specialists to identify potentially problematic IHs within the first 2-3 weeks of life so that they can be treated during the early stage of proliferation.
  • #28 Infantile Hemangioma Workup: Laboratory Studies, Imaging Studies, Procedures
    https://emedicine.medscape.com/article/1083849-workup
    No laboratory studies have been universally accepted for the diagnosis and treatment of infantile hemangiomas; however, reports in the literature have investigated the use of serum vascular endothelial growth factor (VEGF) as well as urinary beta-fibroblast growth factor, VEGF, and matrix metalloproteinases (MMPs) as markers of hemangioma proliferation and differentiation. […] Use of glucose transporter 1 (GLUT-1) stain is helpful for evaluating tissue removed during biopsy or excision. […] MRI with and without intravenous gadolinium is the imaging modality of choice to delineate the location and extent of both cutaneous and extracutaneous hemangiomas. […] If the diagnosis is in question after a thorough history and physical examination, a skin biopsy can be helpful in distinguishing unusual or atypical hemangiomas from other vascular lesions. […] Specimens may be evaluated for tissue-specific immunohistochemical markers such as GLUT-1, merosin, Fc-gamma-RII, and Lewis Y antigens. These markers may aid in differentiating infantile hemangiomas (positive staining for all) from other vascular neoplasms or malformations.
  • #29 Hemangioma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538232/
    Hemangiomas, colloquially termed „strawberry marks”, are the most common benign tumor of infancy and are caused by endothelial cell proliferation. […] Most Infantile hemangiomas are diagnosed clinically. A skin biopsy can be performed if there is any doubt. Infantile hemangiomas stain positive for GLUT 1. Imaging studies like ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are indicated to confirm the diagnosis and the extent of deep IH without superficial changes. This is done to rule out associated anomalies and to differentiate proliferating IH from other tumors. […] The prognosis is very good for uncomplicated IH and there is complete involution in the majority of cases. 50% of hemangiomas will resolve in 5 years, 70% by 7 years and 90% by 9 years. Approximately 8% of IH leave cosmetic disfigurement and require some intervention.
  • #30 Infantile Hemangioma Workup: Laboratory Studies, Imaging Studies, Procedures
    https://emedicine.medscape.com/article/1083849-workup
    No laboratory studies have been universally accepted for the diagnosis and treatment of infantile hemangiomas; however, reports in the literature have investigated the use of serum vascular endothelial growth factor (VEGF) as well as urinary beta-fibroblast growth factor, VEGF, and matrix metalloproteinases (MMPs) as markers of hemangioma proliferation and differentiation. […] Use of glucose transporter 1 (GLUT-1) stain is helpful for evaluating tissue removed during biopsy or excision. […] MRI with and without intravenous gadolinium is the imaging modality of choice to delineate the location and extent of both cutaneous and extracutaneous hemangiomas. […] If the diagnosis is in question after a thorough history and physical examination, a skin biopsy can be helpful in distinguishing unusual or atypical hemangiomas from other vascular lesions. […] Specimens may be evaluated for tissue-specific immunohistochemical markers such as GLUT-1, merosin, Fc-gamma-RII, and Lewis Y antigens. These markers may aid in differentiating infantile hemangiomas (positive staining for all) from other vascular neoplasms or malformations.
  • #31 Infantile haemangioma: Definition and pathogenesis
    https://dermnetnz.org/topics/infantile-haemangioma-definition-and-pathogenesis
    Infantile haemangioma is usually a clinical diagnosis and investigations are not routinely indicated. Investigations may be considered if the diagnosis is uncertain, to define extent and associations, or monitor response to therapy. […] Tests may include: Doppler ultrasonography, MRI for suspected anatomical associations such as PHACE, SACRAL, LUMBAR and PELVIS syndromes, laryngoscopy to investigate stridor with or without beard lesions, for visceral involvement thyroid and liver function tests, ultrasound of abdomen, MRI or ultrasound of the head, or echocardiogram, skin biopsy shows uniform vessel morphology with an outer layer of pericytes and inner lining of endothelial cells containing typical microtubular Weibel-Palade bodies, immunohistochemical staining for GLUT1 confirms a diagnosis of infantile haemangioma, although GLUT1 is also positive in angiosarcoma, epithelioid endothelioma, angiokeratoma, and verrucous haemangioma. Staining is negative in congenital haemangioma and other vascular malformations.
  • #32 Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review
    https://www.mdpi.com/2227-9067/11/11/1397
    Histopathologically, IHs in the proliferative phase consist of lobular clusters of capillaries lined by plump, mitotically active endothelial cells surrounded by pericytes. […] For IHs at risk of complications, early referral to a specialised centre is recommended to enable timely intervention and improve therapeutic outcomes. […] To determine whether a patient should be referred to a specialised centre, paediatricians can use the Infantile Haemangioma Referral Score (IHReS), a validated assessment tool developed by an international group of experts and tested by paediatricians. […] The primary care paediatrician and/or the outpatient dermatologist, when suspecting the presence of an IH but lacking specific knowledge on the subject, may use the IHReS scale as a diagnostic aid to determine if a patient with a suspected or confirmed IH should start treatment with propranolol.
  • #33 Hemangioma – Symptoms, diagnosis and treatment | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/1041
    Benign vascular lesions that typically appear during the first weeks of life as blue or pink macules or patches. […] Some lesions can be problematic, requiring identification and early treatment and/or referral. […] Key diagnostic factors include variable onset, pink, red, or blue color, rapid growth, variable compressibility, and flat or nodular character. […] 1st tests to order include Doppler ultrasound of hemangioma. […] Tests to consider include MRI (without and with IV contrast) of hemangioma and biopsy of lesion.
  • #34 Infantile hemangioma: timely diagnosis and treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8566800/
    Infantile hemangiomas (IHs) are usually diagnosed clinically. Biopsy and pathological diagnosis are required only when the IH lesion must be differentiated from borderline or malignant vascular tumors. […] A patient with IH who is at risk of complications should be referred to a multidisciplinary team for evaluation, specific diagnostic measures (e.g., magnetic resonance imaging, screening for hypothyroidism, or coagulation abnormalities), and specific treatment. […] The early detection of at-risk IHs is a major point requiring increased awareness by pediatricians, general practitioners, and health specialists to identify potentially problematic IHs within the first 2-3 weeks of life so that they can be treated during the early stage of proliferation. […] While the majority of infantile hemangiomas (IHs) do not require therapy and regress spontaneously, about 10%-15% develop complications such as ulceration, obstruction, or disfigurement. Early intervention is recommended for infants with potentially problematic IHs. Oral propranolol 2-3 mg/kg/day is currently the treatment of choice.
  • #35 Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review
    https://www.mdpi.com/2227-9067/11/11/1397
    Histopathologically, IHs in the proliferative phase consist of lobular clusters of capillaries lined by plump, mitotically active endothelial cells surrounded by pericytes. […] For IHs at risk of complications, early referral to a specialised centre is recommended to enable timely intervention and improve therapeutic outcomes. […] To determine whether a patient should be referred to a specialised centre, paediatricians can use the Infantile Haemangioma Referral Score (IHReS), a validated assessment tool developed by an international group of experts and tested by paediatricians. […] The primary care paediatrician and/or the outpatient dermatologist, when suspecting the presence of an IH but lacking specific knowledge on the subject, may use the IHReS scale as a diagnostic aid to determine if a patient with a suspected or confirmed IH should start treatment with propranolol.
  • #36 Hemangioma – Vascular Birthmarks Foundation
    https://birthmark.org/birthmark/hemangioma/
    Hemangioma is a benign, blood-filled tumor. […] Early and accurate diagnosis and treatment is key. […] To assure the best outcome in treating any congenital lesion (birthmark) the doctor has to first be sure what it is. Early and accurate diagnosis leads to the correct treatment. The wrong diagnosis leads to treatment that is useless. […] The correct diagnosis is critical for proper treatment. […] Early intervention and/or referral (ideally by 1 month of age) is recommended for infants who have potentially problematic Infantile Hemangiomas. […] The important thing to remember is that accurate diagnosis and early intervention is key. […] Read the 2019 American Academy of Pediatrics (AAP) Clinical Practice Guidelines for the Management of Hemangiomas for the latest in research and treatment. […] Early Treatment of Problematic Infantile Hemangiomas. […] New AAP Guidelines for Infantile Hemangioma: Prompt treatment when needed for best outcomes.
  • #37
    https://practicaldermatology.com/news/from-aslms-advances-in-infantile-hemangioma-diagnosis-and-care/2474328/
    New guidelines from the International Society for the Study of Vascular Anomalies (ISSVA) offer more precise classification and improved multidisciplinary pathways for patient care. […] Dr. Kelly emphasized the importance for dermatologists to accurately distinguish between vascular tumors and malformations to guide appropriate diagnostic workup, referrals, and treatment strategies. […] The 2025 ISSVA update classified vascular tumors into benign, borderline, and malignant groups while expanding categories for vascular malformations. […] Dr. Kelly urged clinicians to review the updated classification system, reminding attendees that accurate subclassification is essential for prognosis and treatment planning. […] In cases of large, segmental infantile hemangiomas, Dr. Kelly said physicians should consider syndromic associations such as PHACE syndrome, necessitating cardiac imaging and ophthalmologic evaluation.
  • #38 Types of Hemangiomas, Treatment & Diagnosis, NYC Dermatologist
    https://www.michelegreenmd.com/medical/hemangioma
    Dr. Green is available to examine any infantile hemangiomas and discuss treatment options for unsightly or disfiguring hemangiomas. […] If a child presents with six or more infantile hemangiomas, it is common practice to examine the liver and spleen to detect any internal hemangiomas. […] Internal hemangioma can be confirmed through a computed tomography (CT) scan, Magnetic Resonance Imaging (MRI), or ultrasound. […] Hemangiomas usually go away by the time a child reaches ten years of age. […] Consulting a board-certified healthcare provider with a pediatric background, such as Dr. Green in NYC, is the best way to remove a hemangioma and resolve any residual effects.
  • #39 Infantile haemangioma: Definition and pathogenesis
    https://dermnetnz.org/topics/infantile-haemangioma-definition-and-pathogenesis
    Infantile haemangioma is usually a clinical diagnosis and investigations are not routinely indicated. Investigations may be considered if the diagnosis is uncertain, to define extent and associations, or monitor response to therapy. […] Tests may include: Doppler ultrasonography, MRI for suspected anatomical associations such as PHACE, SACRAL, LUMBAR and PELVIS syndromes, laryngoscopy to investigate stridor with or without beard lesions, for visceral involvement thyroid and liver function tests, ultrasound of abdomen, MRI or ultrasound of the head, or echocardiogram, skin biopsy shows uniform vessel morphology with an outer layer of pericytes and inner lining of endothelial cells containing typical microtubular Weibel-Palade bodies, immunohistochemical staining for GLUT1 confirms a diagnosis of infantile haemangioma, although GLUT1 is also positive in angiosarcoma, epithelioid endothelioma, angiokeratoma, and verrucous haemangioma. Staining is negative in congenital haemangioma and other vascular malformations.
  • #40 Liver Hemangioma: What it Is, Causes, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17784-liver-hemangioma
    Liver hemangiomas are the most common type of benign liver lesions. They dont turn into cancerous tumors. […] A liver hemangioma (hepatic hemangioma) is a noncancerous tumor in your liver. […] Liver hemangiomas in adults and children are generally nothing to worry about. […] Liver hemangiomas are the most common type of benign liver lesions. They occur in approximately 5% of the population. […] Since most dont cause symptoms, most are diagnosed incidentally. […] Imaging tests that can identify a liver hemangioma include: Contrast-enhanced ultrasound, Computed tomography (CT) scan, Magnetic resonance imaging (MRI), X-ray contrast, A nuclear liver scan. […] Most of the time, imaging tests are enough to tell the two apart. […] If your hemangioma appears to be growing, your healthcare provider may suggest interventions to stop it before it becomes a problem.
  • #41 Hepatic Hemangiomas Workup: Approach Considerations, Laboratory Studies, Imaging Studies
    https://emedicine.medscape.com/article/177106-workup
    Radiologic imaging is the key to making a diagnosis of hepatic hemangioma. The key modalities include ultrasonography, dynamic contrast-enhanced computed tomography (CT) scanning, and magnetic resonance imaging (MRI). Less commonly used imaging modalities include nuclear medicine studies using technetium-99m (99mTc)labeled red blood cells (RBCs), hepatic arteriography, and digital subtraction angiography (DSA). […] Ultrasound has a sensitivity as high as 97% and a specificity as high as 60% in the diagnosis of hepatic hemangioma. […] The American College of Gastroenterology (ACG) and the European Association for the Study of the Liver (EASL) both state that the finding of a small lesion ( 2 cm for ACG; 3 cm for EASL) with classic imaging characteristics in a patient without chronic liver disease or without an oncologic diagnosis can be considered to be diagnostic for hepatic hemangioma.
  • #42 Liver Hemangioma: What it Is, Causes, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17784-liver-hemangioma
    Liver hemangiomas are the most common type of benign liver lesions. They dont turn into cancerous tumors. […] A liver hemangioma (hepatic hemangioma) is a noncancerous tumor in your liver. […] Liver hemangiomas in adults and children are generally nothing to worry about. […] Liver hemangiomas are the most common type of benign liver lesions. They occur in approximately 5% of the population. […] Since most dont cause symptoms, most are diagnosed incidentally. […] Imaging tests that can identify a liver hemangioma include: Contrast-enhanced ultrasound, Computed tomography (CT) scan, Magnetic resonance imaging (MRI), X-ray contrast, A nuclear liver scan. […] Most of the time, imaging tests are enough to tell the two apart. […] If your hemangioma appears to be growing, your healthcare provider may suggest interventions to stop it before it becomes a problem.
  • #43 Hepatic Hemangiomas Workup: Approach Considerations, Laboratory Studies, Imaging Studies
    https://emedicine.medscape.com/article/177106-workup
    Radiologic imaging is the key to making a diagnosis of hepatic hemangioma. The key modalities include ultrasonography, dynamic contrast-enhanced computed tomography (CT) scanning, and magnetic resonance imaging (MRI). Less commonly used imaging modalities include nuclear medicine studies using technetium-99m (99mTc)labeled red blood cells (RBCs), hepatic arteriography, and digital subtraction angiography (DSA). […] Ultrasound has a sensitivity as high as 97% and a specificity as high as 60% in the diagnosis of hepatic hemangioma. […] The American College of Gastroenterology (ACG) and the European Association for the Study of the Liver (EASL) both state that the finding of a small lesion ( 2 cm for ACG; 3 cm for EASL) with classic imaging characteristics in a patient without chronic liver disease or without an oncologic diagnosis can be considered to be diagnostic for hepatic hemangioma.
  • #44 Diagnosis and Management Of Choroidal Hemangiomas | Retinal Physician
    https://www.retinalphysician.com/issues/2013/october/diagnosis-and-management-of-choroidal-hemangiomas/
    Choroidal hemangiomas represent benign hamartomatous vascular tumors that may be confined to the globe or be manifestations of a widespread hemangiomatous disorder. […] The diagnosis of CCH can be challenging. The funduscopic appearance may be similar to that of other amelanotic choroidal lesions, such as an amelanotic choroidal melanoma, choroidal metastasis, posterior scleritis, choroidal granuloma, choroidal osteoma, lymphoma, or atypical central serous retinopathy. […] The decision to treat a CCH should be individualized. The physician should base treatment on the extent of symptoms, loss of vision, and the potential for visual recovery. […] The aim of treatment is to induce sufficient tumor atrophy with resolution of subretinal fluid and reduction in tumor-induced foveal distortion, without destroying the function of the overlying retina.
  • #45 A cavernous hemangioma located in the axillary area: Challenges in preoperative diagnosis and operation
    https://www.kjco.org/journal/view.php?number=336
    Cavernous hemangiomas are benign neoplasms of endothelial cells. […] The patient presented with a palpable mass in the left axilla that was initially thought to be either a phyllodes tumor or a lymphoma based on imaging studies. However, the results of an excisional biopsy led to a diagnosis of cavernous hemangioma. […] Although uncommon, a cavernous hemangioma can be encountered unexpectedly, presenting as a mass in axilla. […] Cavernous hemangiomas are difficult to diagnose preoperatively via conventional imaging techniques as they lack pathognomonic characteristics. […] Diagnosing vascular tumors via core needle biopsy is challenging. […] An excisional biopsy is usually only required when the preoperative core needle biopsy and radiological findings are discordant; in addition to confirming the diagnosis, excisional biopsies can also rule out malignancy, as in the present case.
  • #46 I thought it was a hemangioma! A pictorial essay about common and uncommon liver hemangiomas’ mimickers | Insights into Imaging | Full Text
    https://insightsimaging.springeropen.com/articles/10.1186/s13244-024-01745-1
    Focal liver lesions are frequently encountered during imaging studies, and hemangiomas represent the most common solid liver lesion. Liver hemangiomas usually show characteristic imaging features that enable characterization without the need for biopsy or follow-up. […] The knowledge of imaging features of potential liver hemangiomas mimickers is fundamental to avoid misinterpretation. […] Liver hemangiomas typically show imaging features that enable avoiding a biopsy. […] Many benign and malignant liver lesions show imaging features resembling hemangiomas. […] Radiologists must know the potentially misleading imaging features of hemangiomas mimickers. […] Hemangiomas have peculiar imaging features that enable accurate diagnosis using contrast-enhanced imaging modalities. […] No percutaneous biopsy or surgical resection is needed in cases of lesions with typical US appearance in nononcological patients with healthy liver, as well as in lesions with a typical enhancement pattern.
  • #47 The Evaluation, Diagnosis, and Management of Infantile Hemangiomas—A Comprehensive Review
    https://www.mdpi.com/2077-0383/14/2/425
    Infantile hemangioma (IH) is the most common pediatric benign vascular tumor. […] Diagnosis is usually clinical, and propranolol is currently the mainstay of treatment. […] In most cases, the diagnosis of infantile hemangioma can be established clinically, based on history and physical examination. […] In case of doubt in establishing the diagnosis, especially in the case of segmental lesions, the child should be referred to an appropriately experienced specialist dealing with vascular anomalies. […] High-frequency ultrasound (HFUS) can be particularly useful for the differential diagnosis of deep IHs, as well as for monitoring the dynamics during the treatment of IHs. […] Despite the updated classification, misdiagnosis remains a major obstacle to optimal assessment and treatment. […] A biopsy is rarely indicated, and endothelial GLUT-1 staining is a sensitive marker for IH, which is absent in most other vascular tumors and malformations.
  • #48 Hemangioma – Vascular Birthmarks Foundation
    https://birthmark.org/birthmark/hemangioma/
    Hemangioma is a benign, blood-filled tumor. […] Early and accurate diagnosis and treatment is key. […] To assure the best outcome in treating any congenital lesion (birthmark) the doctor has to first be sure what it is. Early and accurate diagnosis leads to the correct treatment. The wrong diagnosis leads to treatment that is useless. […] The correct diagnosis is critical for proper treatment. […] Early intervention and/or referral (ideally by 1 month of age) is recommended for infants who have potentially problematic Infantile Hemangiomas. […] The important thing to remember is that accurate diagnosis and early intervention is key. […] Read the 2019 American Academy of Pediatrics (AAP) Clinical Practice Guidelines for the Management of Hemangiomas for the latest in research and treatment. […] Early Treatment of Problematic Infantile Hemangiomas. […] New AAP Guidelines for Infantile Hemangioma: Prompt treatment when needed for best outcomes.
  • #49 Hemangioma – Vascular Birthmarks Foundation
    https://birthmark.org/birthmark/hemangioma/
    Hemangioma is a benign, blood-filled tumor. […] Early and accurate diagnosis and treatment is key. […] To assure the best outcome in treating any congenital lesion (birthmark) the doctor has to first be sure what it is. Early and accurate diagnosis leads to the correct treatment. The wrong diagnosis leads to treatment that is useless. […] The correct diagnosis is critical for proper treatment. […] Early intervention and/or referral (ideally by 1 month of age) is recommended for infants who have potentially problematic Infantile Hemangiomas. […] The important thing to remember is that accurate diagnosis and early intervention is key. […] Read the 2019 American Academy of Pediatrics (AAP) Clinical Practice Guidelines for the Management of Hemangiomas for the latest in research and treatment. […] Early Treatment of Problematic Infantile Hemangiomas. […] New AAP Guidelines for Infantile Hemangioma: Prompt treatment when needed for best outcomes.
  • #50 Hemangioma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/hemangioma/diagnosis-treatment/drc-20352339
    In most cases, a health care provider can diagnose a hemangioma by looking at it. Tests typically aren’t needed. […] Most infantile hemangiomas will be harmless to the child. They’ll grow within the first year of life and then slowly go away little by little. However, there are a subset of infantile hemangiomas that can be quite harmful and even have complications that it really should be identified quickly and treated by a specialist. […] The question often comes up when is the best time to have someone that has an infantile hemangioma be seen by a specialist and we did recently complete a study along with some colleagues at the University of California in San Francisco that the most rapid time of growth of an infantile hemangioma is actually the first eight weeks of life, and so if we can alter that rate of growth at some point within that eight weeks that probably leaves a child with the best outcome in the long run.
  • #51 Hemangioma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/hemangioma/diagnosis-treatment/drc-20352339
    Any child where anyone is concerned about the possibility of any complications from their hemangioma ideally should get in with someone that specializes in treating hemangiomas within the first month of life. […] There are now new medications both by mouth and topically depending on the location, size, and the potential complications of a hemangioma that children with hemangiomas can be treated with. […] Here at the Mayo Clinic, I am fortunate enough to be able to work with a great team of doctors who are very invested and very experienced in taking care of children that have infantile hemangiomas.
  • #52 Hemangioma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538232/
    Hemangiomas, colloquially termed „strawberry marks”, are the most common benign tumor of infancy and are caused by endothelial cell proliferation. […] Most Infantile hemangiomas are diagnosed clinically. A skin biopsy can be performed if there is any doubt. Infantile hemangiomas stain positive for GLUT 1. Imaging studies like ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are indicated to confirm the diagnosis and the extent of deep IH without superficial changes. This is done to rule out associated anomalies and to differentiate proliferating IH from other tumors. […] The prognosis is very good for uncomplicated IH and there is complete involution in the majority of cases. 50% of hemangiomas will resolve in 5 years, 70% by 7 years and 90% by 9 years. Approximately 8% of IH leave cosmetic disfigurement and require some intervention.
  • #53 Hemangioma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538232/
    Hemangiomas, colloquially termed „strawberry marks”, are the most common benign tumor of infancy and are caused by endothelial cell proliferation. […] Most Infantile hemangiomas are diagnosed clinically. A skin biopsy can be performed if there is any doubt. Infantile hemangiomas stain positive for GLUT 1. Imaging studies like ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are indicated to confirm the diagnosis and the extent of deep IH without superficial changes. This is done to rule out associated anomalies and to differentiate proliferating IH from other tumors. […] The prognosis is very good for uncomplicated IH and there is complete involution in the majority of cases. 50% of hemangiomas will resolve in 5 years, 70% by 7 years and 90% by 9 years. Approximately 8% of IH leave cosmetic disfigurement and require some intervention.
  • #54 Hemangioma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538232/
    Hemangiomas, colloquially termed „strawberry marks”, are the most common benign tumor of infancy and are caused by endothelial cell proliferation. […] Most Infantile hemangiomas are diagnosed clinically. A skin biopsy can be performed if there is any doubt. Infantile hemangiomas stain positive for GLUT 1. Imaging studies like ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are indicated to confirm the diagnosis and the extent of deep IH without superficial changes. This is done to rule out associated anomalies and to differentiate proliferating IH from other tumors. […] The prognosis is very good for uncomplicated IH and there is complete involution in the majority of cases. 50% of hemangiomas will resolve in 5 years, 70% by 7 years and 90% by 9 years. Approximately 8% of IH leave cosmetic disfigurement and require some intervention.
  • #55 Hemangioma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/hemangioma/diagnosis-treatment/drc-20352339
    In most cases, a health care provider can diagnose a hemangioma by looking at it. Tests typically aren’t needed. […] Most infantile hemangiomas will be harmless to the child. They’ll grow within the first year of life and then slowly go away little by little. However, there are a subset of infantile hemangiomas that can be quite harmful and even have complications that it really should be identified quickly and treated by a specialist. […] The question often comes up when is the best time to have someone that has an infantile hemangioma be seen by a specialist and we did recently complete a study along with some colleagues at the University of California in San Francisco that the most rapid time of growth of an infantile hemangioma is actually the first eight weeks of life, and so if we can alter that rate of growth at some point within that eight weeks that probably leaves a child with the best outcome in the long run.
  • #56 Capillary Hemangioma – EyeWiki
    https://eyewiki.org/Capillary_Hemangioma
    The typical course of capillary hemangiomas is characterized by initial enlargement followed by spontaneous regression. […] Hence, the management of capillary hemangiomas depends on the location and whether the lesion causes visual impairment. Indications for treatment include risk of amblyopia, optic nerve compression, exposure keratopathy, severe cosmetic defect, infection and necrosis. […] Surgical excision remains an option, usually reserved for cases where conservative therapy has failed or was suboptimal, and tumor removal is necessary.
  • #57 Hemangiomas Diagnosis & Treatment | ColumbiaDoctors Children’s Health
    https://www.columbiadoctors.org/childrens-health/centers-programs/vascular-anomalies-program/conditions-we-treat/hemangiomas
    Hemangiomas are non-cancerous tumors that are red or strawberry-colored when they are located on the skins surface and blue-purple when they are in the deeper skin layers. […] Many hemangiomas will disappear without scarring; however, some hemangiomas will leave behind skin changes and scarring. […] Predicting which hemangiomas have the potential to cause problems is essential when making treatment decisions. […] Congenital hemangiomas may shrink but do not fully go away. […] When hemangiomas resolve they might leave behind skin changes or a scar that can affect a child’s self-esteem. […] The FDA has approved the use of oral propranolol, a beta blocker, to treat infantile hemangiomas. […] Laser therapy treatment used for selected infantile hemangiomas to destroy the blood vessels and help the skin return to normal color and texture. […] Surgery an option for certain hemangiomas and can be used to manage skin changes left behind when the hemangiomas regress. […] Although most hemangiomas are not dangerous many hemangiomas can leave significant scars, and there are ways to improve the long-term outcome of your childs hemangioma.
  • #58 Diagnosis of Hemangiomas | Oncohema Key
    https://oncohemakey.com/diagnosis-of-hemangiomas/
    Diagnosis of hemangiomas is based first on the medical history. Two questions are of paramount importance: Was the lesion present at birth? Did proportional or disproportional growth of the lesion after birth occur? […] A careful history that includes age of onset, color, and location, along with physical examination findings, is generally sufficient in determining the pathological condition. The presence of the lesion at birth supports the diagnosis of vascular malformation or congenital hemangioma. […] In cases in which clinical examination alone is inconclusive, other diagnostic modalities such as ultrasonography and magnetic resonance imaging (MRI) may be utilized. […] The appropriate diagnostic tests for congenital hemangiomas are ultrasonography with Doppler and magnetic resonance imaging. […] Imaging is mostly useful for confirming the clinical diagnosis, estimating the extent of the lesion and determining the feasibility of surgical resection.
  • #59 Diagnosis of Hemangiomas | Oncohema Key
    https://oncohemakey.com/diagnosis-of-hemangiomas/
    Diagnosis of hemangiomas is based first on the medical history. Two questions are of paramount importance: Was the lesion present at birth? Did proportional or disproportional growth of the lesion after birth occur? […] A careful history that includes age of onset, color, and location, along with physical examination findings, is generally sufficient in determining the pathological condition. The presence of the lesion at birth supports the diagnosis of vascular malformation or congenital hemangioma. […] In cases in which clinical examination alone is inconclusive, other diagnostic modalities such as ultrasonography and magnetic resonance imaging (MRI) may be utilized. […] The appropriate diagnostic tests for congenital hemangiomas are ultrasonography with Doppler and magnetic resonance imaging. […] Imaging is mostly useful for confirming the clinical diagnosis, estimating the extent of the lesion and determining the feasibility of surgical resection.
  • #60 Diagnosis of Hemangiomas | Oncohema Key
    https://oncohemakey.com/diagnosis-of-hemangiomas/
    Diagnosis of hemangiomas is based first on the medical history. Two questions are of paramount importance: Was the lesion present at birth? Did proportional or disproportional growth of the lesion after birth occur? […] A careful history that includes age of onset, color, and location, along with physical examination findings, is generally sufficient in determining the pathological condition. The presence of the lesion at birth supports the diagnosis of vascular malformation or congenital hemangioma. […] In cases in which clinical examination alone is inconclusive, other diagnostic modalities such as ultrasonography and magnetic resonance imaging (MRI) may be utilized. […] The appropriate diagnostic tests for congenital hemangiomas are ultrasonography with Doppler and magnetic resonance imaging. […] Imaging is mostly useful for confirming the clinical diagnosis, estimating the extent of the lesion and determining the feasibility of surgical resection.
  • #61 Missed Diagnosis: Infantile Hemangioma or Arteriovenous Malformation? Clinical Case
    http://www.fortunejournals.com/articles/missed-diagnosis-infantile-hemangioma-or-arteriovenous-malformation-clinical-case.html
    Infantile hemangioma (IH) is represented by proliferation of endothelium pathological vessels in infants. […] For diagnosis, it is enough to take into account the data of anamnesis, clinical picture and sonography. […] The correct diagnosis is based on the data of anamnesis and clinical manifestations. […] With typical manifestations, the diagnosis of IH is simple and does not require additional diagnostic methods. […] In rare cases, it is possible to conduct an immunohistochemical study to verify the diagnosis, for this purpose the GLUT-1 marker produced by IH cells is used. […] To make a correct diagnosis, it is necessary to take into account not only the anamnesis data, the clinical picture, but also to compare them with ultrasound data. […] In the presence of atypical manifestations that are not characteristic of the results of ultrasound, it is necessary to conduct an in-depth differential diagnosis, possibly with an immunohistochemical examination to confirm the diagnosis.
  • #62 Infantile hemangioma: timely diagnosis and treatment
    http://e-cep.org/journal/view.php?doi=10.3345/cep.2021.00752
    Infantile hemangiomas (IHs) are usually diagnosed clinically. […] Biopsy and pathological diagnosis are required only when the IH lesion must be differentiated from borderline or malignant vascular tumors. […] Imaging studies and other investigations are required in special situations. […] A patient with IH who is at risk of complications should be referred to a multidisciplinary team for evaluation, specific diagnostic measures (e.g., magnetic resonance imaging, screening for hypothyroidism, or coagulation abnormalities), and specific treatment. […] The early detection of at-risk IHs is a major point requiring increased awareness by pediatricians, general practitioners, and health specialists to identify potentially problematic IHs within the first 2-3 weeks of life so that they can be treated during the early stage of proliferation.